Energy and utilities stocks were in focus as market chatter highlighted shifting demand trends, policy updates, and fresh volatility in commodities. Traders are watching closely how global supply factors and rate outlook shape the sector’s next move. $XLE $DUK $NEE

Today's full list: $NVDA | $MSFT | $AAPL | $AMZN | $GXAI | $PRFX | $LASE | $ADD | $FLXS | $LIDR. It's Tuesday, a key day for setting the week's trend. Let's see if we get a strong move from this list. Want my entry and exit ideas? They are shared live in the WhatsApp group.

Today's Stock Recommendation: $PRFX Buy price: $1.39 $PRFX has a strong intellectual property position. The company holds patents that protect its unique extended-release formulation technology, creating a solid competitive moat for its lead drug candidate.

Today's Stock Recommendation: $LASE Buy price: $2.49 At its core, $LASE is a technology disruptor. Its CleanTech laser systems are replacing outdated, dirty, and dangerous methods like sandblasting and chemical cleaning, which are being phased out by new regulations.

Goldman Sachs says the potential market for crypto stablecoins could reach trillions of dollars. A sign of how digital assets are moving deeper into mainstream finance as demand for dollar-linked tokens accelerates. $USDT $USDC $BTC

Looking for a strong Wednesday: $NBY | $SISI | $PPCB | $RCKT | $AUUD | $GES | $TIVC | $NVDA | $MSFT | $AAPL | $GOOG | $TGNA. Let's see if the healthcare space gets active today. $RCKT, $NBY, and $TIVC are all on my screen. Get my watchlist for the week first in the WhatsApp.

Today's Stock Recommendation: $SISI Buy price: $4.97 In a proactive move to ensure market stability, $SISI recently completed a reverse stock split. This necessary action was taken to maintain its compliance with the Nasdaq's minimum bid price requirement.

Today's Stock Recommendation: $THAR Buy price: $1.21 The path forward is clear for $THAR. Following the positive safety data, the company is on track to begin the next phase of its study (Phase 1b) in patients with chronic liver disease later this year, a key execution step.

Boston landlord Kambiz Shahbazi says the value of his four office towers has plunged as Covid fallout and tenant exits continue to weigh on commercial real estate. A stark sign of the sector’s ongoing struggle to recover. $BXP $VNO $ARE

Pre-market thoughts for today: $APM, $PTIX, $THAR, $NVDA, $MSFT, $RENT, $SLQT, $CATO, $AEG, $MC. The reaction to $NVDA's earnings will be a big test for the stock market's strength this Thursday. My top plays are shared in the WhatsApp group.

Today's Stock Recommendation: $APM Buy price: $1.23 A key regulatory catalyst is on the horizon for $APM. The company plans to submit an Investigational New Drug (IND) application to the FDA for SACT-1 for neuroblastoma in the second half of this year.

Today's Stock Recommendation: $PTIX Buy price: $2.28 $PTIX is providing hope for those left behind by current drugs. Patients with TRD often cycle through numerous medications over many years without finding relief, highlighting the urgent need for new options.

📈 Another strong breakout — $APM. The ceiling gave way on high volume, signaling a decisive shift in trend. Momentum supports further upside, and the chart structure agrees. That’s 3 consecutive breakout setups our team executed perfectly.

The Hang Seng Indexes will add Pop Mart, JD Logistics, and China Telecom to its Hong Kong benchmark. The reshuffle highlights shifting sector dynamics as consumer, logistics, and telecom names gain more weight in the market.

Here's my complete list for today: $NVDA, $MSFT, $AAPL, $GOOG, $GH, $ITW, $LIMN, $ELAB, $FMFC, $UI, $NEGG, $RADX. $NEGG is always a fun one to watch on a Friday. I'm looking for any big volume spikes from retail traders. Get my exclusive thoughts in the WhatsApp trading group.

Today's Stock Recommendation: $ELAB Buy price: $1.90 $ELAB is a pure-play on the booming medical aesthetics market. The company is perfectly positioned to benefit from strong and growing consumer demand for non-invasive and minimally invasive cosmetic procedures.

Today's Stock Recommendation: $ACMR Buy price: $25.66 $ACMR is a founder-led company. CEO Dr. David Wang, a respected expert in the semiconductor equipment industry, founded the company and continues to guide its strategic vision and technological innovation.

Trump, eager to secure the Nobel Peace Prize, now claims credit for ending at least eight wars. A closer look shows the reality is far more complex. $SPY $GLD $USO

A week of well-managed risk and solid rewards. Our highest-conviction setup, $UI, hit its target with a +30.64% gain. The rest of our carefully selected basket—$TCRT, $ANTE, $ACMR, & $LIMN — all delivered as expected, making for a successful week. Have a great weekend.